Last update June 30, 2015
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Azelastine in other languages or writings:
Azelastine belongs to these groups or families:
Main tradenames from several countries containing Azelastine in its composition:
|Protein Binding||80 - 90||%|
|Tmax||2 - 5||hours|
|T½||22 - 35||hours|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Second generation anti-histaminic drug with low sedative effect. Used for ophthalmic and nasal topical administration.
On last update no relevant published data related to breastfeeding were found.
A small dose together with a low plama level of most nasal and ophthalmologic compounds make that a significant excretion into breast milk would be unlikely.